CorporateServe launches PharmaSoft 2.0

The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity

Shilpa Biologics permitted to conduct Phase 1 study on NavAlbumin

The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent

U.S. FDA approves ANI’s purified cortrophin gel

Cortrophin gel is purified corticotropin (ACTH), an important treatment option for patients struggling with certain chronic autoimmune disorders. It acquired the NDA for cortrophin gel from Merck & Co. in 2016

Novartis AG wins case against four domestic pharma firms

The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech

Lancet endorses Sputnik Light for safety and immune response

Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries

Covaxin shelf-life extended to 12 months from the date of manufacture

This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO

WHO issues emergency use listing for Covaxin

This is the eighth Covid-19 vaccine to receive Emergency Use Listing

EMA encourages companies to submit type I variations by end- November

Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 3rd December 2021 for a start of procedure in 2021

Samsung Receives FDA clearance for AI algorithms detecting lung nodules in X-rays

It provides an option to automatically perform nodule detection immediately after chest X-ray imaging

Transforming Healthcare Through AI